SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is trending due to a potential short squeeze, with the community actively discussing its low float and comparing it to other high-momentum stocks like $SMX. Traders are eyeing key price levels and potential catalysts related to the company's expansion into digital finance and global payments, despite some concerns about past reverse splits and potential delisting.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst news of acquiring Warner Bros., a deal met with mixed reactions from the community. While some investors see long-term strategic value and content library benefits, others express concerns over the deal's massive debt load, potential regulatory hurdles, and impact on the streaming landscape, leading to high trading volume and price volatility.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Wheeler Real Estate Investment Trust Inc

WHLR is trending as traders discuss its potential for a short squeeze, drawing comparisons to SMX due to its low float and high short interest. The community is actively debating potential price movements, with some anticipating a significant upward surge while others caution against the company's history of reverse splits and dilution. High trading volume and increasing cost to borrow are also fueling the conversation around WHLR.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a massive, rapid price surge, sparking intense debate about a potential short squeeze and its sustainability. The community is buzzing with discussions around high volatility, potential for further gains, and comparisons to other high-flying stocks. Some traders caution against chasing the rally, while others remain bullish, citing the low float and potential for continued upward momentum.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses its potential to break out and reclaim ground against BTC and ETH. Some are comparing Litecoin's chart to Nvidia's, while others point to its upcoming halving event as a catalyst. Discussion also centers on Litecoin's transactional utility and potential role in a broader crypto ecosystem.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies is trending following news of former pharmaceutical executive Martin Shkreli taking a large investment position and setting a near-term price target of $100. The community is buzzing about the stock's potential as a high-performance computing play, drawing comparisons to other recent high-flying stocks with tight floats. Some investors point to the company's technology and connection to the World Economic Forum as additional bullish signals.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending due to recent strong earnings and revenue growth, particularly with IBSRELA, exceeding expectations. The community is discussing potential catalysts like the upcoming nephrology conference and the China National Reimbursement Drug List (NRDL). Some are concerned with the stock's inability to hold gains while others are optimistic about long-term growth and potential for M&A.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as community members actively debate the stock's valuation and potential for a short squeeze, with some citing a Yahoo Plus research report to support their bullish outlook. Others remain skeptical, pointing to insider selling and a lack of revenue as reasons to be bearish on the stock within the quantum computing sector. Overall, discussion revolves around the stock's potential for growth versus its current fundamentals.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss the potential for a buyout or strategic partnership, particularly following promising data in lung, prostate, and pancreatic cancers. The community believes the company is significantly undervalued with a large short interest, potentially setting it up for a squeeze. Positive commentary from doctors and analysts, particularly Seshu, are also driving positive sentiment.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne ($S) is trending as investors debate the stock's reaction to earnings; despite a revenue beat and positive outlook, the stock experienced a dip, sparking discussions about potential buyouts, long-term growth prospects, and management effectiveness. Community members are actively weighing the company's valuation against its peers in the cybersecurity sector, considering both its AI capabilities and market positioning.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

&quot;The estimates keep rising. We think it could be anywhere between a $100 billion and $150 billion market, which would make it one of the largest pharmaceutical markets in the world,&quot; noted Tema CIO Yuri Khodjamirian, CFA in a recent Investor&#39;s Business Daily article from Allison Gatlin: https://www.investors.com/news/technology/weight-loss-drugs-how-outliers-like-biohaven-regeneron-are-trying-to-squeeze-into-the-obesity-space 
 
He underscores that as companies vie for a share of this market, it&#39;s clear that innovation and patient-centric solutions will be key to success, and there&#39;s room for more than one winner. Check out the full piece here: 
 
#WeightLoss #Pharmaceuticals $HRTS $LLY $NVO

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Investor's Business Daily

There's A Problem With Today's Obesity Drugs - How These Companies Are Solving It

StockTwits Web

Lilly(Eli) & Co

Novo Nordisk A/S

GLP-1, Obesity & Cardiometabolic ETF

"The estimates keep rising. We think it could be anywhere between a $100 billion and $150 billion market, which would make it one of the largest pharmaceutical markets in the world," noted Tema CIO Yuri Khodjamirian, CFA in a recent Investor's Business Daily article from Allison Gatlin: 

 
 
He underscores that as companies vie for a share of this market, it's clear that innovation and patient-centric solutions will be key to success, and there's room for more than one winner. Check out the full piece here: 
 
